Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BJM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,348
Award facts
- Contract value 100% obligated
- $25,347.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $25,347.85, represents the company's continued role as a critical pharmaceutical supplier to federal military and healthcare systems. The order is expected to be completed by December 15, 2025, with fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the company competed for this requirement through open federal procurement channels.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an approximately $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen's comprehensive IDC enables the company to supply diverse pharmaceutical products, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal health systems including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen maintains a significant presence in the military's medical supply chain and continues to be positioned as a potential contractor under the Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DR26F9BJM?
SPE2DR26F9BJM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F9BJM worth?
The government has obligated $25,348 on SPE2DR26F9BJM.
Is contract SPE2DR26F9BJM an order under another contract?
Yes. SPE2DR26F9BJM is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BJM competed?
The extent of competition for SPE2DR26F9BJM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award